Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Endocrinology | Family Medicine
 Disease Category: Endometriosis
Location: United States, MN

Trial Information

Endometriosis

The purpose of this study is to test the safety and effectiveness of different doses of elagolix compared to placebo (inactive substance) in managing moderate to severe pain associated with endometriosis.

Patient Inclusion Critiera:

  • Premenopausal female between 18 and 49 years of age.

Patient Exclusion Critiera:

  • History of severe, life threatening or other significant sensitivity to any drug.
  • Currently pregnant or breastfeeding.
  • HIV
  • Hysterectomy
  • Fibroids
  • Irritable Bowel Syndrome
  • Fibromyalgia

Kristy Ebert, Research Project Associate
Ridgeview Research
111 Hundertmark Road, Ste. 410
Chaska, MN 55318
Phone: 952-556-2686
Fax: 952-556-2688
Email: kristy.ebert@ridgeviewmedical.org

View Map

Research Center Information: Ridgeview Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.